These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2161935)
1. Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates. Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow CA; Reardon IM; Chaudhary VK; Fryling CM; Pastan I; Fitzgerald DJ J Virol; 1990 Jul; 64(7):3157-61. PubMed ID: 2161935 [TBL] [Abstract][Full Text] [Related]
2. Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease. Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; FitzGerald DJ; Chaudhary VK; Pastan I; Heinrikson RL J Biol Chem; 1990 Jan; 265(1):408-13. PubMed ID: 2104621 [TBL] [Abstract][Full Text] [Related]
3. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691 [TBL] [Abstract][Full Text] [Related]
4. Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV. Nashed NT; Louis JM; Sayer JM; Wondrak EM; Mora PT; Oroszlan S; Jerina DM Biochem Biophys Res Commun; 1989 Sep; 163(2):1079-85. PubMed ID: 2551268 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. Cameron CE; Grinde B; Jacques P; Jentoft J; Leis J; Wlodawer A; Weber IT J Biol Chem; 1993 Jun; 268(16):11711-20. PubMed ID: 8389361 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins. Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099 [TBL] [Abstract][Full Text] [Related]
7. Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites. Bagossi P; Sperka T; Fehér A; Kádas J; Zahuczky G; Miklóssy G; Boross P; Tözsér J J Virol; 2005 Apr; 79(7):4213-8. PubMed ID: 15767422 [TBL] [Abstract][Full Text] [Related]
8. Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates. Kotler M; Danho W; Katz RA; Leis J; Skalka AM J Biol Chem; 1989 Feb; 264(6):3428-35. PubMed ID: 2536748 [TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides as substrates and inhibitors of a retroviral protease. Kotler M; Katz RA; Danho W; Leis J; Skalka AM Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4185-9. PubMed ID: 2837759 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites. Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736 [TBL] [Abstract][Full Text] [Related]
12. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Matayoshi ED; Wang GT; Krafft GA; Erickson J Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161 [TBL] [Abstract][Full Text] [Related]
13. In vitro cleavage of avian retrovirus gag proteins by viral protease p15. Vogt VM; Wight A; Eisenman R Virology; 1979 Oct; 98(1):154-67. PubMed ID: 90424 [No Abstract] [Full Text] [Related]
14. Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site. Eizert H; Bander P; Bagossi P; Sperka T; Miklóssy G; Boross P; Weber IT; Tözsér J J Virol; 2008 Oct; 82(20):10111-7. PubMed ID: 18701588 [TBL] [Abstract][Full Text] [Related]
15. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406 [TBL] [Abstract][Full Text] [Related]